Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer.

@article{Montgomery2002IsosulfanBD,
  title={Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer.},
  author={Leslie L. Montgomery and Alisa C Thorne and Kimberly J Van Zee and Jane V Fey and Alexandra S. Heerdt and Mary L Gemignani and Elisa Port and Jeanne A. Petrek and Hiram S. Cody and Patrick Ivan Borgen},
  journal={Anesthesia and analgesia},
  year={2002},
  volume={95 2},
  pages={385-8, table of contents}
}
UNLABELLED In the United States, identification of the sentinel lymph node (SLN) requires the use of (99m)Tc-labeled colloid, 1% isosulfan blue dye, or both to trace the lymphatic drainage of a given neoplasm. We report our experience with adverse reactions to isosulfan blue dye during SLN mapping in breast cancer. A chart review of the breast cancer SLN database was performed; it included 2392 sequential patients who underwent SLN biopsy involving isosulfan blue dye at Memorial Sloan-Kettering… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 75 extracted citations

Similar Papers

Loading similar papers…